肺鳞癌-话题@MedSci

#肺鳞癌#

34篇内容 | 2305人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1391476, encodeId=4eaa13914e649, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=【NCCN更新】帕博利珠单抗联合化疗——晚期肺鳞癌患者一线治疗新选择, objectType=article, longId=147733, objectId=907414e73367, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=907414e73367, replyNumber=0, likeNumber=131, createdTime=2018-08-31, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=907414e73367, moduleTitle=【NCCN更新】帕博利珠单抗联合化疗——晚期肺鳞癌患者一线治疗新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=907414e73367)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391475, encodeId=1c4d13914e5fd, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=病例分享：1例ALK重排肺鳞癌患者的治疗, objectType=article, longId=144502, objectId=588d144502a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=588d144502a0, replyNumber=0, likeNumber=72, createdTime=2018-07-17, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=588d144502a0, moduleTitle=病例分享：1例ALK重排肺鳞癌患者的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=588d144502a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391474, encodeId=dad513914e44c, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=程颖教授：安罗替尼再亮剑，晚期肺鳞癌新突破, objectType=article, longId=139930, objectId=648d13993059, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=648d13993059, replyNumber=0, likeNumber=77, createdTime=2018-06-06, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=648d13993059, moduleTitle=程颖教授：安罗替尼再亮剑，晚期肺鳞癌新突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=648d13993059)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391473, encodeId=d6ef13914e3c7, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=Cancer Res：中国学者揭示靶向YAP是抑制肺鳞癌恶性进展的潜在新策略, objectType=article, longId=124690, objectId=a524124690b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a524124690b6, replyNumber=0, likeNumber=61, createdTime=2017-12-28, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a524124690b6, moduleTitle=Cancer Res：中国学者揭示靶向YAP是抑制肺鳞癌恶性进展的潜在新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a524124690b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391472, encodeId=cd4713914e219, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=Chest：确诊临床IA期肺鳞癌后多久手术合适？, objectType=article, longId=116776, objectId=6c55116e766d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c55116e766d, replyNumber=0, likeNumber=79, createdTime=2017-10-20, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c55116e766d, moduleTitle=Chest：确诊临床IA期肺鳞癌后多久手术合适？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c55116e766d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391471, encodeId=3a7613914e1c4, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=EGFR基因突变/ALK基因融合阳性肺鳞癌的靶向治疗, objectType=article, longId=107808, objectId=dadd10e80888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dadd10e80888, replyNumber=0, likeNumber=90, createdTime=2017-08-06, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dadd10e80888, moduleTitle=EGFR基因突变/ALK基因融合阳性肺鳞癌的靶向治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dadd10e80888)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391470, encodeId=3e6813914e079, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=【盘点】近期肺鳞癌重要研究汇总, objectType=article, longId=79830, objectId=022de983037, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022de983037, replyNumber=0, likeNumber=68, createdTime=2016-10-13, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022de983037, moduleTitle=【盘点】近期肺鳞癌重要研究汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=022de983037)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391469, encodeId=aa56139146986, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=Cell Res：季红斌发现新的肺鳞癌致病融合基因TRA2B-DNAH5, objectType=article, longId=79045, objectId=7fbfe904525, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fbfe904525, replyNumber=0, likeNumber=60, createdTime=2016-10-01, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fbfe904525, moduleTitle=Cell Res：季红斌发现新的肺鳞癌致病融合基因TRA2B-DNAH5, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fbfe904525)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391468, encodeId=01f1139146805, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=张嵩：肺鳞癌和腺鳞癌的影像诊断和治疗, objectType=article, longId=68702, objectId=1e0768e028b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e0768e028b, replyNumber=0, likeNumber=72, createdTime=2016-05-21, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e0768e028b, moduleTitle=张嵩：肺鳞癌和腺鳞癌的影像诊断和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e0768e028b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391467, encodeId=f567139146e1c, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=ECC 2015：晚期肺鳞癌治疗进展, objectType=article, longId=56879, objectId=4285568e9e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4285568e9e2, replyNumber=0, likeNumber=59, createdTime=2015-10-06, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4285568e9e2, moduleTitle=ECC 2015：晚期肺鳞癌治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4285568e9e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391466, encodeId=19301391466a1, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=ASCO 2015：前瞻性TKI 直接比较的晚期肺鳞癌研究，阿法替尼总生存期更优（LUX-Lung 8）, objectType=article, longId=51535, objectId=af6f5153537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af6f5153537, replyNumber=0, likeNumber=55, createdTime=2015-06-04, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af6f5153537, moduleTitle=ASCO 2015：前瞻性TKI 直接比较的晚期肺鳞癌研究，阿法替尼总生存期更优（LUX-Lung 8）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af6f5153537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391465, encodeId=4fcc139146515, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=ESMO 2014：肺鳞癌、头颈鳞癌：阿法替尼好戏连台, objectType=article, longId=41299, objectId=25e141299c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25e141299c6, replyNumber=0, likeNumber=63, createdTime=2014-10-17, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25e141299c6, moduleTitle=ESMO 2014：肺鳞癌、头颈鳞癌：阿法替尼好戏连台, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25e141299c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391464, encodeId=e70413914641b, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=ASCO 2014：nab-PC和GC一线治疗晚期肺鳞癌的II期研究, objectType=article, longId=35670, objectId=7ec2356e0f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ec2356e0f8, replyNumber=0, likeNumber=79, createdTime=2014-06-02, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ec2356e0f8, moduleTitle=ASCO 2014：nab-PC和GC一线治疗晚期肺鳞癌的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ec2356e0f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391463, encodeId=8c8a1391463d8, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=ASCO 2014：Necitumumab联合GC较单纯GC化疗显著改善Ⅳ期肺鳞癌的OS, objectType=article, longId=35664, objectId=2abe35664c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2abe35664c2, replyNumber=0, likeNumber=65, createdTime=2014-06-02, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2abe35664c2, moduleTitle=ASCO 2014：Necitumumab联合GC较单纯GC化疗显著改善Ⅳ期肺鳞癌的OS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2abe35664c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391462, encodeId=f3d1139146268, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=Chest：复旦陈海泉等发现肺鳞癌致癌基因突变特征, objectType=article, longId=31055, objectId=7a203105532, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a203105532, replyNumber=0, likeNumber=57, createdTime=2014-02-26, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a203105532, moduleTitle=Chest：复旦陈海泉等发现肺鳞癌致癌基因突变特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a203105532)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391461, encodeId=7fa013914612f, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=Nat Commun：Kras/Lkb1/Lox可能是肺腺癌向肺鳞癌转化的关键分子机制, objectType=article, longId=30843, objectId=6e0630843d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e0630843d0, replyNumber=0, likeNumber=105, createdTime=2014-02-21, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e0630843d0, moduleTitle=Nat Commun：Kras/Lkb1/Lox可能是肺腺癌向肺鳞癌转化的关键分子机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e0630843d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391460, encodeId=7dfa139146037, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=Nature：发现一个新的肺鳞癌治疗靶点, objectType=article, longId=9743, objectId=755d9e4388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=755d9e4388, replyNumber=0, likeNumber=77, createdTime=2012-09-15, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=755d9e4388, moduleTitle=Nature：发现一个新的肺鳞癌治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=755d9e4388)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肺鳞癌

2020-05-29

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

【NCCN更新】帕博利珠单抗联合化疗——晚期肺鳞癌患者一线治疗新选择

2018-08-31

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

病例分享：1例ALK重排肺鳞癌患者的治疗

2018-07-17

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

程颖教授：安罗替尼再亮剑，晚期肺鳞癌新突破

2018-06-06

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

Cancer Res：中国学者揭示靶向YAP是抑制肺鳞癌恶性进展的潜在新策略

2017-12-28

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

Chest：确诊临床IA期肺鳞癌后多久手术合适？

2017-10-20

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

EGFR基因突变/ALK基因融合阳性肺鳞癌的靶向治疗

2017-08-06

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

【盘点】近期肺鳞癌重要研究汇总

2016-10-13

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

Cell Res：季红斌发现新的肺鳞癌致病融合基因TRA2B-DNAH5

2016-10-01

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

张嵩：肺鳞癌和腺鳞癌的影像诊断和治疗

2016-05-21

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

ECC 2015：晚期肺鳞癌治疗进展

2015-10-06

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

ASCO 2015：前瞻性TKI 直接比较的晚期肺鳞癌研究，阿法替尼总生存期更优（LUX-Lung 8）

2015-06-04

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

ESMO 2014：肺鳞癌、头颈鳞癌：阿法替尼好戏连台

2014-10-17

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

ASCO 2014：nab-PC和GC一线治疗晚期肺鳞癌的II期研究

2014-06-02

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

ASCO 2014：Necitumumab联合GC较单纯GC化疗显著改善Ⅳ期肺鳞癌的OS

2014-06-02

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

Chest：复旦陈海泉等发现肺鳞癌致癌基因突变特征

2014-02-26

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

Nat Commun：Kras/Lkb1/Lox可能是肺腺癌向肺鳞癌转化的关键分子机制

2014-02-21

ms9476844295372110 (审核中...)

前往app查看评论内容

#肺鳞癌#

Nature：发现一个新的肺鳞癌治疗靶点

2012-09-15

科室
- - 订阅+
  - 更多科室
工具
服务